Molecular testing in oncology: problems, pitfalls and progress.
about
Barriers prevent patient access to personalized therapies identified by molecular tumor profiling of gynecologic malignancies.Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFR-mutated NSCLC patient and successful management by adding ALK inhibitors: a case report.Epiregulin as a therapeutic target in non-small-cell lung cancerCancer diagnostics: The journey from histomorphology to molecular profiling.Endorsing good quality assurance practices in molecular pathology: risks and recommendations for diagnostic laboratories and external quality assessment providers.How to make Mathematics Biology's next and better microscope.A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer.
P2860
Q35824457-ADC20479-06C2-41F0-88CE-6877EA544631Q35916214-CBEB61A9-31AD-4BB4-B87A-1F794B7688C7Q37566850-29E1BBCC-7FBA-4FDA-A1E2-3948C20DA586Q38559476-69E022F4-AE0F-4EF2-9734-B13C5532FB64Q38573698-CDEDA384-4AB8-49DD-9C9C-573301E597A8Q42361342-606B0C29-FE16-4267-A754-E8D0C6374434Q55016872-4BA6AE38-B375-405A-AB5D-AF53353276B1
P2860
Molecular testing in oncology: problems, pitfalls and progress.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular testing in oncology: problems, pitfalls and progress.
@en
type
label
Molecular testing in oncology: problems, pitfalls and progress.
@en
prefLabel
Molecular testing in oncology: problems, pitfalls and progress.
@en
P50
P1433
P1476
Molecular testing in oncology: problems, pitfalls and progress
@en
P2093
Sarah E Taylor
P304
P356
10.1016/J.LUNGCAN.2013.12.010
P577
2014-01-03T00:00:00Z